Health Catalyst Revenue vs. Net Income

HCAT Stock  USD 2.45  0.05  2.00%   
Based on Health Catalyst's profitability indicators, Health Catalyst may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in February. Profitability indicators assess Health Catalyst's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2018-03-31
Previous Quarter
80.7 M
Current Value
76.3 M
Quarterly Volatility
18.3 M
 
Covid
At this time, Health Catalyst's Days Sales Outstanding is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.19 in 2026, whereas Price Sales Ratio is likely to drop 1.52 in 2026. At this time, Health Catalyst's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 21.7 M in 2026, whereas Net Loss is likely to drop (65.7 M) in 2026. Gross Profit is likely to drop to about 106.7 M in 2026. Pretax Profit Margin is likely to drop to -0.21 in 2026
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.50.53
Notably Down
Slightly volatile
For Health Catalyst profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Health Catalyst to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Health Catalyst utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Health Catalyst's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Health Catalyst over time as well as its relative position and ranking within its peers.
Check out Risk vs Return Analysis.
For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.The next projected EPS of Health Catalyst is estimated to be 0.0513 with future projections ranging from a low of 0.045 to a high of 0.0625. Health Catalyst's most recent 12-month trailing earnings per share (EPS TTM) is at -1.58. Please be aware that the consensus of earnings estimates for Health Catalyst is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Health Catalyst is projected to generate 0.0513 in earnings per share on the 31st of December 2025. Health Catalyst earnings estimates show analyst consensus about projected Health Catalyst EPS (Earning Per Share). It derives the highest and the lowest estimates based on Health Catalyst's historical volatility. Many public companies, such as Health Catalyst, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Health Catalyst's earnings estimates, investors can diagnose different trends across Health Catalyst's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Health Catalyst. If investors know Health will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.58)
Revenue Per Share
4.666
Return On Assets
(0.05)
Return On Equity
(0.31)
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Catalyst's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Health Catalyst Net Income vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Health Catalyst's current stock value. Our valuation model uses many indicators to compare Health Catalyst value to that of its competitors to determine the firm's financial worth.
Health Catalyst is rated as one of the top companies in revenue category among its peers. It is rated # 5 in net income category among its peers . At this time, Health Catalyst's Total Revenue is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Health Catalyst by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Health Revenue vs. Competition

Health Catalyst is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 537.24 Million. Health Catalyst totals roughly 306.58 Million in revenue claiming about 57% of equities under Health Care industry.

Health Net Income vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Health Catalyst

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
306.58 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Health Catalyst

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(69.5 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Health Net Income Comparison

Health Catalyst is currently under evaluation in net income category among its peers.

Health Catalyst Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Health Catalyst, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Health Catalyst will eventually generate negative long term returns. The profitability progress is the general direction of Health Catalyst's change in net profit over the period of time. It can combine multiple indicators of Health Catalyst, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-751.5 K-713.9 K
Net Interest IncomeM1.1 M
Interest Income20.7 M21.7 M
Operating Income-62.8 M-66 M
Net Loss-62.6 M-65.7 M
Income Before Tax-62.3 M-65.4 M
Non Operating Income Net Other-7.7 M-7.3 M
Total Other Income Expense Net732.5 K769.2 K
Net Loss-123.7 M-129.8 M
Net Loss-62.6 M-65.7 M
Income Tax Expense299.7 K314.7 K
Change To Netincome76.2 M43.3 M
Net Loss(1.04)(1.09)
Income Quality(0.24)(0.23)
Net Income Per E B T 1.16  1.09 

Health Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Health Catalyst. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Health Catalyst position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Health Catalyst's important profitability drivers and their relationship over time.

Health Catalyst Earnings Estimation Breakdown

The calculation of Health Catalyst's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Health Catalyst is estimated to be 0.0513 with the future projection ranging from a low of 0.045 to a high of 0.0625. Please be aware that this consensus of annual earnings estimates for Health Catalyst is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.06
0.04
Lowest
Expected EPS
0.0513
0.06
Highest

Health Catalyst Earnings Projection Consensus

Suppose the current estimates of Health Catalyst's value are higher than the current market price of the Health Catalyst stock. In this case, investors may conclude that Health Catalyst is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Health Catalyst's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
1220.2%
0.06
0.0513
-1.58

Health Catalyst Earnings History

Earnings estimate consensus by Health Catalyst analysts from Wall Street is used by the market to judge Health Catalyst's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Health Catalyst's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Health Catalyst Quarterly Gross Profit

37.82 Million

Price Earnings To Growth Ratio is likely to gain to 0.13 in 2026, whereas Retained Earnings are likely to drop (1.1 B) in 2026. Common Stock Shares Outstanding is likely to drop to about 45.6 M in 2026. Net Loss is likely to drop to about (129.8 M) in 2026.
Hype
Prediction
LowEstimatedHigh
0.122.476.80
Details
Intrinsic
Valuation
LowRealHigh
0.152.987.31
Details
13 Analysts
Consensus
LowTargetHigh
3.593.944.38
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.040.050.06
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Health Catalyst. Your research has to be compared to or analyzed against Health Catalyst's peers to derive any actionable benefits. When done correctly, Health Catalyst's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Health Catalyst. Note that many institutional investors and large investment bankers can move markets due to the volume of Health assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Health Catalyst. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Health Catalyst's stock price in the short term.

Health Catalyst Earnings per Share Projection vs Actual

Actual Earning per Share of Health Catalyst refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Health Catalyst predict the company's earnings will be in the future. The higher the earnings per share of Health Catalyst, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Health Catalyst Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Health Catalyst, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Health Catalyst should always be considered in relation to other companies to make a more educated investment decision.

Health Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Health Catalyst's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-11
2025-09-300.06290.06-0.0029
2025-08-07
2025-06-300.04-0.59-0.631575 
2025-05-07
2025-03-310.030.01-0.0266 
2025-02-20
2024-12-310.07640.04-0.036447 
2024-11-06
2024-09-300.10.07-0.0330 
2024-08-07
2024-06-300.080.120.0450 
2024-05-09
2024-03-310.030.050.0266 
2024-02-22
2023-12-31-0.00020.020.020210100 
2023-10-27
2023-09-30-0.020.030.05250 
2023-08-08
2023-06-30-0.020.050.07350 
2023-05-09
2023-03-31-0.040.050.09225 
2023-02-28
2022-12-31-0.11-0.050.0654 
2022-11-08
2022-09-30-0.19-0.130.0631 
2022-08-04
2022-06-30-0.1-0.030.0770 
2022-05-10
2022-03-31-0.11-0.060.0545 
2022-03-01
2021-12-31-0.21-0.190.02
2021-11-09
2021-09-30-0.22-0.180.0418 
2021-08-05
2021-06-30-0.14-0.00170.138398 
2021-05-06
2021-03-31-0.15-0.060.0960 
2021-02-25
2020-12-31-0.19-0.160.0315 
2020-11-10
2020-09-30-0.27-0.210.0622 
2020-08-11
2020-06-30-0.22-0.150.0731 
2020-05-12
2020-03-31-0.25-0.160.0936 
2020-02-27
2019-12-31-0.29-0.210.0827 
2019-11-12
2019-09-30-0.37-0.270.127 
2019-08-22
2019-06-30-0.3-0.210.0930 
2019-04-10
2019-03-310-2.17-2.17

Use Health Catalyst in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Health Catalyst position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Catalyst will appreciate offsetting losses from the drop in the long position's value.

Health Catalyst Pair Trading

Health Catalyst Pair Trading Analysis

The ability to find closely correlated positions to Health Catalyst could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Health Catalyst when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Health Catalyst - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Health Catalyst to buy it.
The correlation of Health Catalyst is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Health Catalyst moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Health Catalyst moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Health Catalyst can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Health Catalyst position

In addition to having Health Catalyst in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Asset Allocation ETFs Thematic Idea Now

Asset Allocation ETFs
Asset Allocation ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Asset Allocation ETFs theme has 183 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Asset Allocation ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Health Stock Analysis

When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.